The Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society, recognizes the distinguished physicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA.
Improved compensation, expanded mentorship and training opportunities, and concrete measures to improve workforce diversity are all needed to address attrition from the ranks of physician scientists specializing in infectious diseases...
The Infectious Diseases Society of America (IDSA) announced today the recipients of its Antimicrobial Stewardship Centers of Excellence (CoE) designation.
Obese adults shed influenza A virus for a longer time than adults who were not obese, according to a new JID study.
Ensuring that Medicare physician reimbursement promotes quality care was a key topic of today’s House Energy and Commerce Committee Health Subcommittee hearing.
With a key provision supporting the development of a trained and ready public health workforce, and new efforts to combat antimicrobial resistance, the Pandemic and All Hazards Preparedness Act reauthorization bill approved by the House Energy and Commerce Committee Wednesday addresses issues that are essential to ensuring we have the resources and capacities we will need to confront emerging threats to public health.
Today the National Academies of Science, Engineering and Medicine released Integrating Responses at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics, a report documenting the proceedings of a two-day meeting of public health, drug policy and law enforcement experts, including leaders of the Infectious Diseases Society of America and the HIV Medicine Association.
House Foreign Affairs Africa, Global Health, Global Human Rights and International Organization subcommittee members today will hear from global health leaders on tuberculosis challenges for the first time in the nearly three years since the World Health Organization announced the disease has become the world’s leading infectious killer.
The Senate Appropriations Committee has firmly pushed back on White House proposals for funding cuts to global and domestic health programs and biomedical research, as the Infectious Diseases Society of America and other organizations concerned with our nation’s health have urged.
Advances in rapid molecular testing mean infectious diseases can be accurately diagnosed in minutes or hours rather than days or weeks and patients can receive appropriate treatment sooner.
The consequences to individual and public health of continuing “zero-tolerance” border policies and of large scale detention of thousands of weakened and vulnerable individuals will be longstanding and far-reaching.
The spending bill released Friday by the Senate Appropriations State and Foreign Operations subcommittee, proposing the first increase in funding for the U.S. President’s Emergency Plan for AIDS Relief in nearly a decade, and the robust increase proposed by the House Appropriations State and Foreign Operations subcommittee for USAID’s global efforts to combat tuberculosis, demonstrate a welcome awareness of the tremendous value of continued U.S. leadership of crucial global health responses.